BIO-RSA versus Metal Augments in Reverse Shoulder Arthroplasty: A Prospective, Randomized Clinical Trial with Two-year Follow-up

2021 ◽  
Author(s):  
Madeleine L. Van de Kleut ◽  
Xunhua Yuan ◽  
Matthew G. Teeter ◽  
George S. Athwal
Keyword(s):  
Clinical Trial ◽  
Randomized Clinical Trial ◽  
Shoulder Arthroplasty ◽  
Reverse Shoulder Arthroplasty ◽  
Prospective Randomized Clinical Trial

scholarly journals Influence of Biologically Oriented Preparation Technique on Peri-Implant Tissues; Prospective Randomized Clinical Trial with Three-Year Follow-Up. Part I: Hard Tissues

2019 ◽  
Vol 8 (12) ◽  
pp. 2183 ◽  
Author(s):  
Rubén Agustín-Panadero ◽  
Naia Bustamante-Hernández ◽  
María Fernanda Solá-Ruíz ◽  
Álvaro Zubizarreta-Macho ◽  
Antonio Fons-Font ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Bone Loss ◽  
Randomized Clinical Trial ◽  
Preparation Technique ◽  
Crown Group ◽  
Clinical Behavior ◽  
Prospective Randomized Clinical Trial ◽  
Hard Tissues ◽  
Functional Loading

Purpose: The objective of this prospective randomized clinical trial (RCT) was to analyze and compare the clinical behavior of three types of prosthesis supported by single implants in the posterior region after three years functional loading. Materials and Methods: Seventy-five implants were divided into three groups according to the type of prosthetic restoration: screw-retained crown (Group GS); cemented crown without finishing line (biologically oriented preparation technique) (Group GBOPT); and conventional cemented crown with finishing line (Group GCC). The clinical behavior of each restoration type was analyzed after 3 years functional loading by analyzing radiographic peri-implant bone loss. Results: GBOPT obtained the least bone loss (p < 0.01) in comparison with GS and GCC. Conclusions: Bone loss around implants is related to the type of prosthetic restoration it supports, whereby cemented BOPT crowns present less bone loss.

scholarly journals The MELFO-Study: Prospective, Randomized, Clinical Trial for the Evaluation of a Stage-adjusted Reduced Follow-up Schedule in Cutaneous Melanoma Patients—Results after 1 Year

2016 ◽  
Vol 23 (9) ◽  
pp. 2762-2771 ◽  
Author(s):  
Samantha Damude ◽  
Josette E. H. M. Hoekstra-Weebers ◽  
Anne Brecht Francken ◽  
Sylvia ter Meulen ◽  
Esther Bastiaannet ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Randomized Clinical Trial ◽  
Cutaneous Melanoma ◽  
Prospective Randomized Clinical Trial ◽  
Melanoma Patients

Hyaluronidase Versus Surgical Excision of Ganglia: A Prospective, Randomized Clinical Trial

2002 ◽  
Vol 27 (3) ◽  
pp. 256-258 ◽  
Author(s):  
M. JAGERS OP AKKERHUIS ◽  
M. VAN DER HEIJDEN ◽  
P. R. G. BRINK
Keyword(s):  
Clinical Trial ◽  
Randomized Clinical Trial ◽  
Recurrence Rate ◽  
Surgical Excision ◽  
Prospective Randomized Clinical Trial ◽  
Surgical Group

This prospective, randomized clinical trial compared the treatment of ganglia by either hyaluronidase injection and aspiration or surgical excision. Fifty patients were randomly allocated to each group and 46 patients in the hyaluronidase group and 43 in the surgical group were available for follow-up at 1 year. Patients with ganglia treated with hyaluronidase had a recurrence rate of 77%, which was significantly higher ( P<0.01) than the recurrence rate after surgery (24%).

Sign in / Sign up

Export Citation Format

Share Document